Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 5Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Motor Activity 2Gastrointestinal Neoplasms 2Vitamin D Deficiency 1Stomach Neoplasms 1Rectal Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Lung Neoplasms 1Inflammation 1Hypertension 1Heart Diseases 1Fibrosis 1Esophageal Neoplasms 1Coronary Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 235Leucovorin 209Irinotecan 152Radiotherapy 139Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 49Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Vitamin D × Gastrointestinal × Clear all
NCT01150877 2017-03-03

High Dose Vitamin D Study

University of British Columbia

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡